AngioJet Ultra血栓清除装置用于EVAR后髂支闭塞的经皮机械治疗
本研究回顾性分析452例肾下腹主动脉瘤患者,其中12例随访期间发生髂支闭塞,采用AngioJet Ultra血栓清除装置联合髂动脉血管成形术治疗。手术成功率100%,平均手术时间2.4小时,住院4.5天,随访12个月无下肢缺血。结论认为该装置作为EVAR后髂支闭塞的辅助治疗安全、有效、微创。
要点
- AngioJet Ultra联合髂动脉成形术治疗EVAR后髂支闭塞技术成功率100%。
- 术后间歇性跛行/臀部跛行逐渐消失,随访12个月无下肢缺血。
- 2例出现血红蛋白尿,其中1例轻度肾功能不全。
核心结论
- AngioJet Ultra血栓清除装置作为腹主动脉EVAR后髂支闭塞的辅助治疗安全、有效且微创。
研究设计与样本
- 回顾性分析452例肾下腹主动脉瘤患者,其中12例随访期间发生髂支闭塞并接受AngioJet Ultra联合髂动脉血管成形术治疗。
主要发现
- 12例患者均为男性,平均年龄62.8±11.8岁;左侧髂支闭塞4例,右侧8例。
- 手术成功率为100%;9例在AngioJet Ultra血栓清除和球囊扩张血管成形术后成功植入分叉型覆膜支架,3例成功植入一体型覆膜支架。
- 平均手术时间2.4小时,平均住院4.5天;术后间歇性跛行/臀部跛行逐渐消失。
- 2例出现血红蛋白尿,其中1例发生轻度肾功能不全;12例平均随访12个月,均无下肢缺血。
临床怎么用
- 对于EVAR后髂支闭塞,可考虑使用AngioJet Ultra血栓清除装置联合髂动脉血管成形术进行经皮机械治疗。
局限性
- 本研究为回顾性分析,样本量小(12例),随访时间平均12个月,结论需更大样本和更长随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the safety and efficacy of applying the AngioJet Ultra thrombectomy device in treating endograft occlusions in the iliac arteries following endovascular aneurysm repair (EVAR). METHODS: This study utilized a retrospective analysis of 452 patients with infrarenal abdominal aortic aneurysm (AAA). Twelve of the patients experienced iliac limb occlusion during their follow-up period, and the AngioJet Ultra thrombectomy device was used in tandem with iliac angioplasty to treat these patients. The safety of the device was assessed through the amount of blood drawn, the duration of the procedure, and the occurrence of post-operative complications, while its efficacy was assessed through aortic computed tomography angiography (CTA) imaging and post-operative symptomatology results. RESULTS: All 12 patients were male, and they had a mean age of 62.8 ± 11.8 years. Iliac limb occlusion occurred on the left side of 4 patients and on the right side of 8 patients. The AngioJet Ultra thrombectomy device was used together with iliac angioplasty during surgery, with a success rate of 100%. A bifurcated endograft was successfully implanted in 9 patients following AngioJet Ultra thrombectomy and balloon dilation angioplasty, while a unibody endograft was successfully implanted in 3 patients following AngioJet Ultra thrombectomy and balloon dilation angioplasty. The mean surgery duration was 2.4 hrs, and the patients were hospitalized for an average of 4.5 days. After surgery, the patients' intermittent claudication/buttock claudication gradually vanished. Two patients experienced hemoglobinuria, with one of them developing mild renal dysfunction. Currently, the twelve patients have been followed up for an average of 12 months, and none have experienced any lower extremity ischemia. CONCLUSIONS: The use of the AngioJet Ultra thrombectomy device as a supplementary treatment for iliac limb occlusion following abdominal EVAR is safe, effective, and minimally invasive.
引用
- Han X, Liu G, Li T, et al. Application of the AngioJet Ultra Thrombectomy Device for the Percutaneous Mechanical Treatment (PMT) of Iliac Limb Occlusion after Endovascular Aneurysm Repair (EVAR). Ann Vasc Surg. 2021. PMID: 34474132. doi:10.1016/j.avsg.2021.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。